Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Inez Tinsley-Dalton

Psychiatry Indian Harbour Beach, FL Medical Doctor

NPI 1740468636 CMS profile 79572

2060 A1a Hwy Ste 307, Indian Harbour Beach, FL 32937

Open in the dashboard

General payments

$727

36 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Inez Tinsley-Dalton of Indian Harbour Beach, FL is reported in the CMS Open Payments database as having received $727 across 36 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $251 10
2022 General $46 3
2021 General $119 8
2020 General $98 4
2019 General $213 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Inez Tinsley-Dalton
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Inez Tinsley-Dalton were reported at $251. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Inez Tinsley-Dalton Psychiatry median Middle half National median
2019 $213 $184 $59–$605 $163
2020 $98 $119 $36–$372 $114
2021 $119 $143 $43–$576 $132
2022 $46 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $251 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sunovion Pharmaceuticals Inc. $343 17 payments
  2. ITI, Inc. $202 7 payments
  3. AbbVie, Inc. $105 7 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $61 4 payments
  5. Allergan Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $727 36 payments
Products named General payments · program years 2019–2025
  1. LATUDA $343 17 payments
  2. CAPLYTA $202 7 payments
  3. VRAYLAR Neuroscience $65 4 payments
  4. VRAYLAR Neuroscience $55 4 payments
  5. Trintellix Central Nervous System (CNS) $36 3 payments
  6. TRINTELLIX Neuroscience $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

231

Median for Psychiatry & Neurology: 100

Drug cost

$4,157

Median for Psychiatry & Neurology: $2,986

Branded share of claims

11.3%

Median for Psychiatry & Neurology: 16.2%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Bupropion Xl Bupropion Hcl Brand 12 $893
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 14 $547
Alprazolam Generic 40 $529
Sertraline Hcl Generic 24 $399
Lamotrigine Generic 21 $370
Escitalopram Oxalate Generic 15 $291
Clonazepam Generic 31 $289
Aripiprazole Generic 11 $277
Lorazepam Generic 36 $265
Gabapentin Generic 16 $183

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,755 Part D prescribers listed as Psychiatry & Neurology; they describe a distribution and say nothing about conduct.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record